A review revealed in JAMA Network Open up emphasizes the discrepancy in between what it prices to generate copyright plus the retail charges patients deal with. Regardless of the very low generation fees, Novo Nordisk hasn't publicly disclosed particular figures for copyright or its other item, Wegovy.Thank you for reaching out! Our group will asse